ISSN: 2005-0380
Journal Home
Journal Guideline
Journal of Gynecologic Oncology Q1 Unclaimed
Journal of Gynecologic Oncology is a journal indexed in SJR in Medicine (miscellaneous) and Obstetrics and Gynecology with an H index of 56. It has an SJR impact factor of 1,022 and it has a best quartile of Q1. It has an SJR impact factor of 1,022.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1,022
SJR Impact factor56
H Index113
Total Docs (Last Year)262
Total Docs (3 years)3160
Total Refs768
Total Cites (3 years)226
Citable Docs (3 years)3.18
Cites/Doc (2 years)27.96
Ref/DocOther journals with similar parameters
MMWR. Morbidity and mortality weekly report Q1
Annual Review of Public Health Q1
Annual Review of Clinical Psychology Q1
Journal of Thoracic Oncology Q1
Lancet Digital Health, The Q1
Compare this journals
Aims and Scope
Best articles by citations
ASGO 4th International Workshop on Gynecologic Oncology
View moreRisk factors for early death among ovarian cancer patients: a nationwide cohort study
View moreHighlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology
View moreOvarian conservation for young women with clinical stage IB-IIB cervical cancer in Japan
View moreQuality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB-IIB cervical cancer
View moreArtificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
View moreComparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion
View moreUnenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma
View moreDiagnostic value of integrated 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients
View moreClinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis
View moreThe gate-keeping role of surgeons with regard to endometrial cancers in Lynch syndrome
View moreMultidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
View moreTraditional herbal medicine, Rikkunshito, for chemotherapy-induced nausea and vomiting
View moreThe epidemiologic status of gynecologic cancer in Thailand
View moreBRCA1/2 mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling
View moreOncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB-IIA cervical cancer patients
View moreImpact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer
View moreSurgical management of non-invasive uterine clear cell carcinoma
View moreRisks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study
View moreThe detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye
View morePrognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer
View moreNational screening programs for cervical cancer in Asian countries
View morePerioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer
View moreGynecologic oncology group trials in uterine corpus malignancies: recent progress
View more
Comments